Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study.
Saved in:
| Title: | Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study. |
|---|---|
| Authors: | Peters NA; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Constantinides A; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Ubink I; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., van Kuik J; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Bloemendal HJ; Department of Internal Medicine, Meander Medical Center, Amersfoort, Netherlands.; Department of Internal Medicine/Oncology, Radboud University Medical Center Nijmegen, Nijmegen, Netherlands., van Dodewaard JM; Department of Internal Medicine, Meander Medical Center, Amersfoort, Netherlands., Brink MA; Department of Gastroenterology, Meander Medical Center, Amersfoort, Netherlands., Schwartz TP; Department of Gastroenterology, Meander Medical Center, Amersfoort, Netherlands., Lolkema MPJK; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, Netherlands., Lacle MM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Moons LM; Department of Gastroenterology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Geesing J; Department of Gastroenterology, Diakonessenhuis, Utrecht, Netherlands., van Grevenstein WMU; Department of Surgical Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Roodhart JML; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Elias SG; Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Borel Rinkes IHM; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Department of Surgical Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Kranenburg O; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands. |
| Source: | Frontiers in oncology [Front Oncol] 2022 Sep 06; Vol. 12, pp. 969855. Date of Electronic Publication: 2022 Sep 06 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
